Wednesday, 7 October 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Vista Pharmaceuticals Ltd

NSE: VISTAPH · BSE: 524711 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹6.40
Market cap: ₹39.39 Cr
Revenue (annual): ₹5.40 Cr
Net profit (annual): ₹-12.06 Cr
P/E (TTM): -3.4×Sector 47.4×
Promoter holding: 21.19%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Board Meeting Date 2 Management Change 1 Debt & Borrowing 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 15:30 IST BSE

Financial Results

Vista Pharmaceuticals Q1 FY27 Results: Net Loss of ₹1 Cr, Loss Narrows

Vista Pharmaceuticals Ltd reported a net loss of ₹1 Cr for Q1 FY27.

Key figure: Net loss ₹1 Cr

Open full results → Read the filing ↗

29 May 2026 15:17 IST BSE

Financial Results

Vista Pharmaceuticals Q4 FY26 Results: Net Loss of ₹5.9 Cr, Loss Widens

Vista Pharmaceuticals Ltd reported a net loss of ₹5.9 Cr for Q4 FY26.

Key figure: Net loss ₹5.9 Cr

Open full results → Read the filing ↗

29 May 2026 15:16 IST BSE

Financial Results

Vista Pharmaceuticals Financial Results

Vista Pharmaceuticals reported audited financial results for the year ended March 31, 2026. The company also appointed M/s. LMN & Co. as internal auditors.

Read the filing ↗